Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein, N-His-SUMO

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P10391; research use only.

SKU:
ABM140832-1
Manufacturer SKU
ARO-P10391
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Title: Introduction to Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein, also known as Tumor Necrosis Factor Receptor 1 (TNFR1), is a cell surface receptor that plays a crucial role in the immune response and inflammation. This protein is produced through recombinant technology, making it a valuable tool for research and therapeutic applications. In this article, we will discuss the structure, activity, and applications of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein.

Structure of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is a type I transmembrane glycoprotein that belongs to the TNF receptor superfamily. It is composed of 455 amino acids and has a molecular weight of approximately 55 kDa. The extracellular domain of this protein contains four cysteine-rich domains, which are important for ligand binding. The intracellular domain contains a death domain, which is essential for signaling and activation of downstream pathways.

Activity of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is the primary receptor for tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine that is involved in various physiological and pathological processes. Upon binding to TNF-α, CD120a/TNFRSF1A/TNFR1 Protein forms a trimeric complex, which leads to the activation of downstream signaling pathways. This results in the production of cytokines, chemokines, and other inflammatory mediators, leading to the recruitment of immune cells and the initiation of an immune response.

Applications of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein has a wide range of applications in research and medicine. Here are some of the main applications of this protein:

1. Research: Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is commonly used in research to study the role of TNF-α in various diseases and conditions. It can be used to investigate the signaling pathways activated by TNF-α and the effects of blocking or activating these pathways.

2. Drug development: TNF-α is a major therapeutic target for the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used to screen potential drugs that can block the interaction between TNF-α and its receptor, thereby reducing inflammation.

3. Diagnosis: The levels of TNF-α and its receptor have been found to be elevated in several diseases, making them potential biomarkers for diagnosis and disease monitoring. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used in diagnostic assays to measure the levels of TNF-α and its receptor in patient samples.

4. Immunotherapy: Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein has been investigated as a potential immunotherapeutic agent for the treatment of cancer. By targeting TNF-α, it can modulate the immune response and enhance the anti-tumor activity of immune cells.

5. Vaccine development: TNF-α has been shown to play a role in the immune response to viral infections. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used in vaccine development to enhance the immune response against viral antigens.

Conclusion

Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is a vital tool for studying the role of TNF-α in various diseases and conditions. Its structure and activity make

ProteoGenix catalogue number ARO-P10391. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 22.66 kDa; Fragment: Pro356-Leu441; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
TNFR-I, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor superfamily member 1A, TBPI, p60, CD120a, TNFRSF1A, Tumor necrosis factor receptor type I, p55, TNF-RI, TNFAR, TNFR1, TNF-R1
Host species
E. coli
Source organism
Human
Molecular weight
22.66 kDa
Sequence fragment
Pro356-Leu441
Sequence
PATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEAL
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10391
UniProt accession
P19438
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£169.00£135.20